留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

胰岛移植:寻找新的β细胞来源

穆冰 宋一民 李晓斌 赵玉沛

穆冰, 宋一民, 李晓斌, 赵玉沛. 胰岛移植:寻找新的β细胞来源[J]. 协和医学杂志, 2014, 5(3): 335-338. doi: 10.3969/j.issn.1674-9081.2014.03.018
引用本文: 穆冰, 宋一民, 李晓斌, 赵玉沛. 胰岛移植:寻找新的β细胞来源[J]. 协和医学杂志, 2014, 5(3): 335-338. doi: 10.3969/j.issn.1674-9081.2014.03.018

胰岛移植:寻找新的β细胞来源

doi: 10.3969/j.issn.1674-9081.2014.03.018
详细信息
    通讯作者:

    赵玉沛 电话:010-69155818, E-mail:zhao8028@263.net

  • 中图分类号: R617;R587.1

  • [1] Fiorina P, Shapiro A, Ricordi C, et al. The clinical impact of islet transplantation[J]. Am J Transplantat, 2008, 8:1990-1997. doi:  10.1111/j.1600-6143.2008.02353.x
    [2] Robertson RP, Davis C, Larsen J, et al. Pancreas and islet transplantation in type 1 diabetes[J]. Diabetes Care, 2006, 29:935. doi:  10.2337/diacare.29.04.06.dc06-9908
    [3] Ballinger W, Lacy P. Transplantation of intact pancreatic islets in rats[J]. Surgery, 1972, 72:175. http://europepmc.org/abstract/MED/4262169
    [4] Brendel MD, Hering BJ, Schultz AO, et al. International islet transplant registry report[R/OL]. (1999-08-22)[2013-04-15]. http://www.med.uni-giessen.de/itr/newsletter/newsletter.htm.
    [5] Shapiro AJ, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J]. New Engl J Med, 2000, 343:230-238. doi:  10.1056/NEJM200007273430401
    [6] Shapiro AJ, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation[J]. New Engl J Med, 2006, 355:1318-1330. doi:  10.1056/NEJMoa061267
    [7] Alejandro R, Barton FB, Hering BJ, et al. 2008 Update from the collaborative islet transplant registry[J]. Transplantation, 2008, 86:1783-1788. doi:  10.1097/TP.0b013e3181913f6a
    [8] Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation:1999-2010[J]. Diabetes Care, 2012, 35:1436-1445. doi:  10.2337/dc12-0063
    [9] Deters NA, Stokes RA, Gunton JE. Islet transplantation:factors in short-term islet survival[J]. Arch Immunol Ther Exp, 2011, 59:421-429. doi:  10.1007/s00005-011-0143-0
    [10] Shapiro AJ. State of the art of clinical islet transplantation and novel protocols of immunosuppression[J]. Curr Diab Rep, 2011, 11:345-354. doi:  10.1007/s11892-011-0217-8
    [11] Jung HS, Choi SH, Kim SJ, et al. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors[J]. Clin Transplant, 2007, 21:738-743. http://www.ingentaconnect.com/content/mksg/ctr/2007/00000021/00000006/art00009
    [12] Hirshberg B. Can we justify living donor islet transplantation?[J]. Curr Diab Rep, 2006, 6:307-309. doi:  10.1007/s11892-006-0065-0
    [13] Groth C, Tibell A, Tollemar J, et al. Transplantation of porcine fetal pancreas to diabetic patients[J]. Lancet, 1994, 344:1402-1404. doi:  10.1016/S0140-6736(94)90570-3
    [14] Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts[J]. Lancet, 1998, 352:695-698. doi:  10.1016/S0140-6736(98)07145-1
    [15] Grose S. Critics slam Russian trial to test pig pancreas for diabetics[J]. Nat Med, 2007, 13:390-391. http://www.onacademic.com/detail/journal_1000034764192510_d476.html
    [16] Narushima M, Kobayashi N, Okitsu T, et al. A human β-cell line for transplantation therapy to control type 1 diabetes[J]. Nat Biotechnol, 2005, 23:1274-1282. doi:  10.1038/nbt1145
    [17] Ravassard P, Hazhouz Y, Pechberty S, et al. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion[J]. J Clin Invest, 2011, 121:3589. doi:  10.1172/JCI58447
    [18] Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo[J]. Nat Biotechnol, 2008, 26:443-452. doi:  10.1038/nbt1393
    [19] D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells[J]. Nat Biotechnol, 2006, 24:1392-1401. doi:  10.1038/nbt1259
    [20] Kahan BW, Jacobson LM, Hullett DA, et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells an in vitro model to study islet differentiation[J]. Diabetes, 2003, 52:2016-2024. doi:  10.2337/diabetes.52.8.2016
    [21] McCall M, Toso C, Baetge E, et al. Are stem cells a cure for diabetes?[J]. Clin Sci, 2010, 118:87-97. doi:  10.1042/CS20090072
    [22] Domínguez-Bendala J, Lanzoni G, Inverardi L, et al. Concise review:mesenchymal stem cells for diabetes[J]. Stem Cells Transl Med, 2012, 1:59-63. doi:  10.5966/sctm.2011-0017
    [23] Reading JL, Sabbah S, Busch S, et al. Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation[J]. Curr Opin Organ Transplant, 2013, 18:59-64. doi:  10.1097/MOT.0b013e32835c2adf
    [24] Tang DQ, Wang Q, Burkhardt BR, et al. In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignanttransformation[J]. Am J Stem Cells, 2012, 1:114. http://labs.europepmc.org/abstract/PMC/PMC3402040/reload=0%3Bjsessionid=FXGXNALxeTd1pakNSwBV.50
    [25] Vija L, Farge D, Gautier JF, et al. Mesenchymal stem cells:stem cell therapy perspectives for type 1 diabetes[J]. Diabetes Metab, 2009, 35:85-93. doi:  10.1016/j.diabet.2008.10.003
    [26] Lv S, Cheng J, Sun A, et al. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress[J]. Diabetes Res Clin Pract, 2014, 104:143-154. doi:  10.1016/j.diabres.2014.01.011
    [27] Wang S, Li Y, Zhao J, et al. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model[J]. Biol Blood Marrow Transplant, 2013, 19:538-546. doi:  10.1016/j.bbmt.2013.01.001
    [28] Yang Z, Li K, Yan X, et al. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats[J]. Graefes Arch Clin Exp Ophthalmol, 2010, 248:1415-1422. doi:  10.1007/s00417-010-1384-z
    [29] Kuo YR, Wang CT, Cheng JT, et al. Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes[J]. Plast Reconstr Surg, 2011, 128:872-880. doi:  10.1097/PRS.0b013e3182174329
    [30] Maharlooei MK, Bagheri M, Solhjou Z, et al. Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats[J]. Diabetes Res Clin Pract, 2011, 93:228-234. doi:  10.1016/j.diabres.2011.04.018
    [31] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126:663-676. doi:  10.1016/j.cell.2006.07.024
    [32] Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells[J]. Proc Natl Acad Sci USA, 2010, 107:13426-13431. doi:  10.1073/pnas.1007884107
    [33] Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration[J]. Science, 2008, 322:945-949. doi:  10.1126/science.1162494
    [34] Golestaneh N, Kokkinaki M, Pant D, et al. Pluripotent stem cells derived from adult human testes[J]. Stem Cells Dev, 2009, 18:1115-1125. doi:  10.1089/scd.2008.0347
    [35] Kobayashi T, Yamaguchi T, Hamanaka S, et al. Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells[J]. Cell, 2010, 142:787-799. doi:  10.1016/j.cell.2010.07.039
    [36] Ber I, Shternhall K, Perl S, et al. Functional, persistent, and extended liver to pancreas transdifferentiation[J]. J Biol Chem, 2003, 278:31950-31957. doi:  10.1074/jbc.M303127200
    [37] Yang LJ. Liver stem cell-derived β-cell surrogates for treatment of type 1 diabetes[J]. Autoimmun Rev, 2006, 5:409-413. doi:  10.1016/j.autrev.2005.10.009
    [38] Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature, 2008, 455:627-632. doi:  10.1038/nature07314
    [39] Yang YP, Thorel F, Boyer DF, et al. Context-specific α-to-β-cell reprogramming by forced Pdx1 expression[J]. Genes Dev, 2011, 25:1680-1685. doi:  10.1101/gad.16875711
    [40] Wang R, Klöppel G, Bouwens L. Duct-to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats[J]. Diabetologia, 1995, 38:1405-1411. doi:  10.1007/BF00400600
    [41] Dor Y, Brown J, Martinez OI, et al. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation[J]. Nature, 2004, 429:41-46. doi:  10.1038/nature02520
    [42] Furuyama K, Kawaguchi Y, Akiyama H, et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine[J]. Nat Genet, 2011, 43:34-41. doi:  10.1038/ng.722
  • 加载中
计量
  • 文章访问数:  109
  • HTML全文浏览量:  34
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-07-26
  • 刊出日期:  2014-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!